Dengue: A new challenge

Neurology International

Volumn 4, Issue 3, 2012, Pages 65-70

  Puccioni Sohler, Marzia ^a   Orsini, Marco ^b   Soares, Cristiane N ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL GERAL DE FORTALEZA   (Brazil)

^c HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

Author keywords

Dengue; Neurological manifestations; Treatment

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; NONSTRUCTURAL PROTEIN 3;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIBODY DETECTION; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DENGUE; DENGUE VIRUS 2; DENGUE VIRUS 3; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LABORATORY TEST; MENINGITIS; METABOLIC ENCEPHALOPATHY; MONONEUROPATHY; MYELITIS; MYOSITIS; NEUROLOGY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SEROLOGY; SEROTYPE; VIRUS VIRULENCE;

EID: 84870386959     PISSN: 20358385     EISSN: 20358377     Source Type: Journal    
DOI: 10.4081/ni.2012.e15     Document Type: Review

References (62)

1. Chang GJ. Molecular biology of dengue viruses. Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. London: CAB International; 1997. pp. 175-198.
2. Simmons CP, Farrar J. Changing patterns of dengue epidemiology and implications for clinical management and vaccines. PLoS Med 2009;6:e1000129.
3. San Martín JL, Brathwaite O, Zambrano B. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010;82:128-35.
4. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27: 1-13.
5. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119-30.
6. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva: WHO; 1997.
7. Pancharoen C, Thisyakorn U. Neurological manifestation in dengue patients. Southeast Asian J Trop Med Public Health 2001;32:341-5.
8. Solomon T, Dung NM, Vaughan DW, et al. Neurological manifestations of dengue infection. Lancet 2000;355:1053-8.
9. Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, et al. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology 2009;73:1413-7.
10. Soares CN, Cabral-Castro MJ, Peralta JM, et al. Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J Neurol Sci 2011;303:75-9.
11. Araújo FM, Brilhante RS, Cavalcanti LP, et al. Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzymelinked immunosorbent assay. J Virol Methods 2011;177:128-31.
12. Hommel D, Talarmin A, Deubel V, et al. Dengue encephalitis in French Guiana. Res Virol 1998;149:235-8.
13. Liou LM, Lan SH, Lai CL. Dengue fever with ischemic stroke: a case report. Neurologist 2008;14:40-2.
14. Mathew S, Pandian JD. Stroke in patiens with dengue. J Stroke Cerebrovasc Dis 2010;19:253-6.
15. Murthy JM. Neurological complication of dengue infection. Neurol India 2010;58: 581-4.
16. Lum LC, Lam SK, Choy YS, et al. Dengue encephalitis: a true entity? Am Trop Med Hyg 1996;54:256-9.
17. Thisyakorn U, Thisyakorn C, Limpitikul W, Nisalak A. Dengue infection with central nervous system manifestations. Southeast Asian J Trop Med Public Health 1999;30: 504-6.
18. Miagostovich MP, dos Santos FB, Fumian TM, et al. Complete genetic characterization of a Brazilian dengue virus type 3 strain isolated from a fatal outcome. Mem Inst Oswaldo Cruz 2006;101:307-13.
19. Ramos C, Sánchez G, Pando RH et al. Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 1998;4:465-8.
20. Bordignon J, Strottmann DM, Mosimann AL, et al. Dengue neurovirulence in mice: identification of molecular signatures in the E and NS3 helicase domains. J Med Virol 2007;79:1506-17.
21. Chaturvedi UC, Dhawan R, Khanna M, Mathur A. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 1991;72:859-66.
22. Soares CN, Cabral-Castro MJ, Peralta JM, et al. Meningitis determined by olygosymptomatic Dengue virus type 3 infection: report of a case. J Int Infec Dis 2010; 14:150-2.
23. Rajajee S, Ezhilarasi S, Rajarajan K. Benign acute childhood myositis. Indian J Pediatr 2005;72:399-400.
24. Wasay M, Channa R, Jumani M, et al. Encephalitis and myelitis associated with dengue viral infection clinical and neuroimaging features. Clin Neurol Neurosurg 2008;110:635-40.
25. Sousa AM, Puccioni-Sohler M, Dias AB, et al. Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child. J Infect Chemother 2006;12:396-8.
26. Chimelli L, Hahn MD, Netto MB, et al. Dengue: neuropathological findings in 5 fatal cases from Brazil. Clin Neuropathol 1990;9:157-62.
27. Soares CN, Faria LC, Peralta JM, et al. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 2006;249:19-24.
28. Jackson ST, Mullings A, Bennett F, et al. Dengue infection in patients presenting with neurological manifestations in a dengue endemic population. West Indian Med J 2008;57:373-6.
29. Soares CN, Puccioni-Sohler M. Dengue encephalitis: suggestion for case definition. J Neurol Sci 2011;306:165.
30. Varatharaj A. Encephalitis in the clinical spectrum of dengue infection. Neurol India 2010;58:585-91.
31. Domingues RB, Kuster GW, Onuki-Castro FL, et al. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci 2008;267:36-40.
32. Kennedy PG. Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry 2004;75:10-5.
33. Brito CA, Sobreira S, Cordeiro MT, Lucena-Silva N. Acute disseminated encephalomyelitis in classic dengue. Rev Soc Bras Med Trop 2007;40:236-8.
34. Yamamoto Y, Takasaki T, Yamada K, et al. Acute disseminated encephalomyelitis following dengue fever. J Infect Chemother 2002;8:175-7.
35. Gera C, George U. Acute disseminating encephalomyelitis with hemorrhage following dengue. Neurol India 2010;58:595-6.
36. Sundaram C, Shantveer G, Uppin SG, et al. Acute disseminated encephalomyelitis following dengue hemorrhagic fever. Neurol India 2010;58:599-601.
37. Kunishige M, Mitsui T, Tan BH, et al. Preferential gray matter involvement in dengue myelitis. Neurology 2004;63:1980-1.
38. Misra UK, Kalita J, Syam UK, Dhole TN. Neurological manifestations of dengue virus infection. J Neurol Sci 2006;244:117-22.
39. Miagostovich MP, Ramos RG, Nicol AF, et al. Retrospective study on dengue fatal cases. Clin Neuropathol 1997;16:204-8.
40. Soares CN, Cabral-Castro MJ, Oliveira C, et al. Oligosymptomatic dengue infection: a potential cause of Guillain Barré syndrome. Arq Neuropsiquiatr 2008;66:234-7.
41. Esack A, Teelucksingh S, Singh N. The Guillain Barré syndrome following dengue fever. West Indian Med J 1999;48:36-7.
42. Paul C, Dupont B, Pialoux G. Polyradiculonévrite aiguë secondaire à une dengue. Presse Med 1990;19:1503.
43. Sainte Foie S, Niel L, Moreau JP, et al. Un cas de polyra-diculonévrite associé a une dengue chez une patiente originaire de la Guyane Française. Bull Soc Pathol Exot 1993;86:117-8.
44. Kumar S, Subhashini P. Guillain Barré syndrome occurring in the course of dengue fever. Neurol India 2005;53:250-1.
45. Sulekha C, Kumar S, Philip J. Guillain Barré syndrome following dengue fever: report of 3 cases. Indian Pediatr 2004;41: 948-50.
46. Gaultier C, Angibaud G, Laille M, Lacassin F. Probable syndrome de Miller Fisher au cours d'une dengue de type 2. Rev Neurol 2000;156:169-71.
47. Hughes RAC, Hadden RDM, Gregson NA, Smith KJ. Pathogenesis of Guillain Barré syndrome. J Neuroimmunol 1999;100:74-97.
48. Chappuis F, Justafr JC, Duchunstang L, et al. Dengue fever and long thoracic nerve palsy in a traveller returning from Thailand. J Travel Med 2004;11:112-4.
49. Donnio A, Beral L, Olindo S, et al. Dengue, a new etiology in oculomotor paralysis. Can J Ophthalmol 2010;45:183-4.
50. Ansari MK, Jha S, Nath A. Unilateral diaphragmatic paralysis following dengue infection. Neurol India 2010;58:596-8.
51. Paliwal VK, Garg RK, Juyal R, et al. Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis. J Neurol Sci 2011;300:14-8.
52. Malheiros SMF, Oliveira ASB, Schimidt B, et al. Dengue. Muscle biopsy findings in 15 patients. Arq Neuropsiquiatr 1993;51:159-64.
53. Warke RV, Becerra A, Zawadzka A, et al. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol 2008;89:1605-15.
54. Davis JS, Bourke P. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 2004;38:109-11.
55. Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int J Infect Dis 2004;8:69-80.
56. Lima MR, Nogueira RM, Schatzmayr HG, dos Santos FB. Comparison of three commercially available dengue NS1 antigen capture assays for acute diagnosis of dengue in Brazil. PLoS Negl Trop Dis 2010;4:e738.
57. Huhtamo E, Hasu E, Uzcátegui NY, et al. Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology. J Clin Virol 2010;47:49-53.
58. Yong YK, Thayan R, Chong HT, et al. Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR. Singapore Med J 2007;48: 662-8.
59. Sa-Ngasang A, Anantapreecha S, ANuegoonpipat A, et al. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect 2006;134:820-5.
60. De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004;8:390-8.
61. Cam BV, Fonsmark L, Hue NB, et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001;65:848-51.
62. Schmitz J, Roehrig J, Barrett A, Hombach J. Next generation dengue vaccines: a review of candidates in preclinical development. Vaccine 2011;29:7276-84.